References
- AlmAStjernschantzJ1995Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian latanoprost study groupOphthalmology1021743529098273
- BaunOHeegaardSKessingSV1995The morphology of conjunctiva after long-term topical anti-glaucoma treatment. A quantitative analysisActa Ophthalmol Scand7324257493236
- BroadwayDCGriersonIO’BrienC1994aAdverse effects of topical antiglaucoma medication. I. The conjunctival cell profileArch Ophthalmol1121437457980133
- BroadwayDCGriersonIO’BrienC1994bAdverse effects of topical antiglaucoma medication. II. The outcome of filtration surgeryArch Ophthalmol1121446547980134
- FechtnerRDRealiniT2004Fixed combinations of topical glaucoma medicationsCurr Opin Ophthalmol15132515021225
- FellmanRLSullivanEKRatliffM2002Comparison of travoprost 0.0015% and 0.004% with timolol 0.5% in patients with elevated intraocular pressure: a 6-month, masked, multicenter trialOphthalmology109998100811986110
- GoldbergICunha-VazJJakobsenJE2001Comparison of topical travoprost eye drops given once daily and timolol 0.5% given twice daily in patients with open-angle glaucoma or ocular hypertensionJ Glaucoma104142211711841
- HughesBABacharachJCravenER2005A three-month, multicenter, double-masked study of the safety and efficacy of travoprost 0.004%/timolol 0.5% ophthalmic solution compared to travoprost 0.004% ophthalmic solution and timolol 0.5% dosed concomitantly in subjects with open angle glaucoma or ocular hypertensionJ Glaucoma14392916148589
- KassMAHeuerDKHigginbothamEJ2002The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucomaArch Ophthalmol1207011312049574
- Kobelt-NguyenGGerdthamUGAlmA1998Costs of treating primary open-angle glaucoma and ocular hypertension: a retrospective, observational two-year chart review of newly diagnosed patients in Sweden and the United StatesJ Glaucoma7951049559495
- LavinMJWormaldRPMigdalCS1990The influence of prior therapy on the success of trabeculectomyArch Ophthalmol108154382244836
- NetlandPALandryTSullivanEK2001Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertensionAm J Ophthalmol1324728411589866
- Orengo-NaniaSLandryTVon TressM2001Evaluation of travoprost as adjunctive therapy in patients with uncontrolled intraocular pressure while using timolol 0.5%Am J Ophthalmol132860811730649
- ParrishRKPalmbergPSheuWP2003A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter studyAm J Ophthalmol13568870312719078
- ReardonGSchwartzGFMozaffariE2004Patient persistency with topical ocular hypotensive therapy in a managed care populationAm J Ophthalmol137S31214697909
- SchumanJSKatzGJLewisRA2005Efficacy and safety of a fixed combination of travoprost 0.004%/timolol 0.5% ophthalmic solution once daily for open-angle glaucoma or ocular hypertensionAm J Ophthalmol1402425016086946
- StrohmaierKSnyderEDuBinerH1998The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components. Dorzolamide-Timolol Study GroupOphthalmology1051936449787367
- TopperJEBrubakerRF1985Effects of timolol, epinephrine, and acetazolamide on aqueous flow during sleepInvest Ophthalmol Vis Sci26131594044159